The Allstate Corporation: Target Price Consensus and Analysts Recommendations | ALL | US0200021014

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

207.50USD

Average target price

240.52USD

Spread / Average Target

+15.92%

High Price Target

281.00USD

Spread / Highest target

+35.42%

Low Price Target

176.00USD

Spread / Lowest Target

-15.18%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Goldman Sachs
Wells Fargo Securities
Wolfe Research
Keefe Bruyette & Woods
HSBC
Jefferies & Co.
Piper Sandler
Barclays
JPMorgan Chase
Cantor Fitzgerald
BMO Capital
Mizuho Securities
Autonomous Research
TD Cowen
William Blair & Co.
Morgan Stanley
Argus
Roth Capital Partners
UBS
Citigroup
BofA Securities
Evercore ISI
Raymond James
Roth MKM
Keefe, Bruyette & Woods
Credit Suisse
J.P. Morgan Chase
Deutsche Bank Securities

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

207.50USD

Average target price

240.52USD

Spread / Average Target

+15.92%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Real-time Estimate Cboe BZX Other stock markets 03:11:03 2026-03-11 pm EDT			5-day change	1st Jan Change
204.97 ^USD	-1.22%		-3.96%	-1.18%

Mar. 05	Goldman Sachs Downgrades Allstate to Neutral From Buy, Adjusts Price Target to $231 From $238	MT
Mar. 05	Goldman Sachs Downgrade Allstate to Neutral From Buy, Adjusts Price Target to $231 From $238	MT

Mar. 05	Goldman Sachs Downgrades Allstate to Neutral From Buy, Adjusts Price Target to $231 From $238	MT
Mar. 05	Goldman Sachs Downgrade Allstate to Neutral From Buy, Adjusts Price Target to $231 From $238	MT
Feb. 19	Wells Fargo Trims Allstate Price Target to $227 From $228, Maintains Equal Weight Rating	MT
Feb. 19	Wolfe Research Adjusts Allstate Price Target to $255 From $256, Maintains Outperform Rating	MT
Feb. 11	Keefe Bruyette & Woods Adjusts Allstate PT to $260 From $254, Maintains Outperform Rating	MT
Feb. 09	HSBC Adjusts Price Target on Allstate to $244 From $239, Maintains Buy Rating	MT
Feb. 06	Goldman Sachs Adjusts Price Target on Allstate to $238 From $227, Maintains Buy Rating	MT
Feb. 06	Wells Fargo Adjusts Price Target on Allstate to $228 From $223, Maintains Equalweight Rating	MT
Feb. 06	Jefferies Adjusts Price Target on Allstate to $250 From $248, Maintains Buy Rating	MT
Feb. 06	Wolfe Research Adjusts Price Target on Allstate to $256 From $249, Maintains Outperform Rating	MT
Feb. 05	Piper Sandler Adjusts Allstate Price Target to $252 From $255, Maintains Overweight Rating	MT
Feb. 05	Barclays Adjusts Price Target on Allstate to $207 From $201, Maintains Underweight Rating	MT
Feb. 05	JPMorgan Adjusts Price Target on Allstate to $263 From $260, Maintains Overweight Rating	MT
Feb. 05	Cantor Fitzgerald Adjusts Price Target on Allstate to $220 From $202, Maintains Neutral Rating	MT
Jan. 22	BMO Capital Adjusts Price Target on Allstate to $249 From $244, Maintains Outperform Rating	MT
Jan. 21	BMO Capital Raises Price Target on Allstate to $249 From $244	MT
Jan. 20	Wolfe Research Adjusts Price Target on Allstate to $249 From $244, Maintains Outperform Rating	MT
Jan. 16	HSBC Adjusts Price Target on Allstate to $239 From $240, Maintains Buy Rating	MT
Jan. 14	Mizuho Adjusts Price Target on Allstate to $255 From $254, Maintains Outperform Rating	MT
Jan. 14	Analyst recommendations: Rivian, Applied Materials, Coinbase, Intel, Spotify…
Jan. 13	Wells Fargo Adjusts Price Target on Allstate to $223 From $216, Maintains Equalweight Rating	MT
Jan. 12	Allstate Shares Fall After TD Cowen Downgrade	MT
Jan. 12	Autonomous Research Adjusts Price Target on Allstate to $203 From $202, Maintains Underperform Rating	MT
Jan. 12	TD Cowen Downgrades Allstate to Hold From Buy, Adjusts Price Target to $231 From $224	MT
Dec. 18	Goldman Sachs Adjusts Price Target on Allstate to $243 From $240, Maintains Buy Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	THE ALLSTATE CORPORATION					+15.92%
	TOKIO MARINE HOLDINGS, INC.					+14.67%
	THE TRAVELERS COMPANIES, INC.					+0.15%
	AMERICAN INTERNATIONAL GROUP, INC.					+12.04%
	MS&AD INSURANCE GROUP HOLDINGS, INC.					+6.63%
	FAIRFAX FINANCIAL HOLDINGS LIMITED					+18.37%
	ARCH CAPITAL GROUP LTD.					+13.65%
	INTACT FINANCIAL CORPORATION					+23.09%
	SOMPO HOLDINGS, INC.					+5.36%
	SAMPO OYJ					+14.53%
	Average					+12.44%
	Weighted average by Cap.					+11.84%

Consensus The Allstate Corporation

Equities

ALL

US0200021014

Property & Casualty Insurance

Evolution of the Average Target: The Allstate Corporation

Evolution of the Target Price: The Allstate Corporation

Changes in Analyst Recommendations: The Allstate Corporation

Analysts' recommendations: The Allstate Corporation

Sector Comparison:

Analysts' Consensus

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Analysts' Consensus

Quarterly revenue - Rate of surprise

Consensus The Allstate Corporation

Equities

ALL

US0200021014

Property & Casualty Insurance

Evolution of the Average Target: The Allstate Corporation

Evolution of the Target Price: The Allstate Corporation

Changes in Analyst Recommendations: The Allstate Corporation

Analysts' recommendations: The Allstate Corporation

Sector Comparison: FinancialsInsuranceInsuranceProperty & Casualty InsuranceOther Property & Casualty Insurance

Analysts' Consensus

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Analysts' Consensus

Quarterly revenue - Rate of surprise

Sector Comparison: